• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Delta DNMT3B变体以启动子特异性方式调节DNA甲基化。

Delta DNMT3B variants regulate DNA methylation in a promoter-specific manner.

作者信息

Wang Jie, Bhutani Manisha, Pathak Ashutosh K, Lang Wenhua, Ren Hening, Jelinek Jaroslav, He Rong, Shen Lanlan, Issa Jean-Pierre, Mao Li

机构信息

Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

出版信息

Cancer Res. 2007 Nov 15;67(22):10647-52. doi: 10.1158/0008-5472.CAN-07-1337.

DOI:10.1158/0008-5472.CAN-07-1337
PMID:18006804
Abstract

DNA methyltransferase 3B (DNMT3B) is critical in de novo DNA methylation during development and tumorigenesis. We recently reported the identification of a DNMT3B subfamily, DeltaDNMT3B, which contains at least seven variants, resulting from alternative pre-mRNA splicing. DeltaDNMT3Bs are the predominant expression forms of DNMT3B in human lung cancer. A strong correlation was observed between the promoter methylation of RASSF1A gene but not p16 gene (both frequently inactivated by promoter methylation in lung cancer) and expression of DeltaDNMT3B4 in primary lung cancer, suggesting a role of DeltaDNMT3B in regulating promoter-specific methylation of common tumor suppressor genes in tumorigenesis. In this report, we provide first experimental evidence showing a direct involvement of DeltaDNMT3B4 in regulating RASSF1A promoter methylation in human lung cancer cells. Knockdown of DeltaDNMT3B4 expression by small interfering RNA resulted in a rapid demethylation of RASSF1A promoter and reexpression of RASSF1A mRNA but had no effect on p16 promoter in the lung cancer cells. Conversely, normal bronchial epithelial cells with stably transfected DeltaDNMT3B4 gained an increased DNA methylation in RASSF1A promoter but not p16 promoter. We conclude that promoter DNA methylation can be differentially regulated and DeltaDNMT3Bs are involved in regulation of such promoter-specific de novo DNA methylation.

摘要

DNA甲基转移酶3B(DNMT3B)在发育和肿瘤发生过程中的DNA从头甲基化中起关键作用。我们最近报道了一个DNMT3B亚家族DeltaDNMT3B的鉴定,它包含至少七个变体,是由前体mRNA的可变剪接产生的。DeltaDNMT3B是DNMT3B在人类肺癌中的主要表达形式。在原发性肺癌中,观察到RASSF1A基因而非p16基因(两者在肺癌中都经常因启动子甲基化而失活)的启动子甲基化与DeltaDNMT3B4的表达之间存在很强的相关性,这表明DeltaDNMT3B在肿瘤发生过程中调节常见肿瘤抑制基因启动子特异性甲基化中发挥作用。在本报告中,我们提供了首个实验证据,表明DeltaDNMT3B4直接参与调节人类肺癌细胞中RASSF1A启动子的甲基化。用小干扰RNA敲低DeltaDNMT3B4的表达导致RASSF1A启动子快速去甲基化和RASSF1A mRNA重新表达,但对肺癌细胞中的p16启动子没有影响。相反,稳定转染DeltaDNMT3B4的正常支气管上皮细胞在RASSF1A启动子中DNA甲基化增加,但在p16启动子中没有增加。我们得出结论,启动子DNA甲基化可以被差异调节,并且DeltaDNMT3B参与了这种启动子特异性DNA从头甲基化的调节。

相似文献

1
Delta DNMT3B variants regulate DNA methylation in a promoter-specific manner.Delta DNMT3B变体以启动子特异性方式调节DNA甲基化。
Cancer Res. 2007 Nov 15;67(22):10647-52. doi: 10.1158/0008-5472.CAN-07-1337.
2
Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer.δDNMT3B4/2在非小细胞肺癌中调控RASSF1A启动子特异性DNA甲基化的关键作用
Chin Med J (Engl). 2008 Sep 5;121(17):1712-21.
3
Expression of Delta DNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer.Delta DNMT3B变异体在原发性非小细胞肺癌中的表达及其与p16和RASSF1A启动子甲基化的关系。
Cancer Res. 2006 Sep 1;66(17):8361-6. doi: 10.1158/0008-5472.CAN-06-2031.
4
A novel DNMT3B subfamily, DeltaDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer.一种新型的DNA甲基转移酶3B(DNMT3B)亚家族,即DeltaDNMT3B,是非小细胞肺癌中DNMT3B的主要形式。
Int J Oncol. 2006 Jul;29(1):201-7.
5
The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.DNA甲基转移酶和甲基化CpG结合蛋白的表达与人类肺癌细胞系中p14(ARF)、p16(INK4a)和RASSF1A的甲基化状态无关。
Oncogene. 2002 Jul 18;21(31):4822-9. doi: 10.1038/sj.onc.1205581.
6
DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis.DNA甲基转移酶介导的恶性胶质瘤转录沉默:全基因组微阵列和启动子阵列联合分析
Oncogene. 2009 Jul 23;28(29):2667-77. doi: 10.1038/onc.2009.122. Epub 2009 May 25.
7
Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation.RAS致癌基因介导的转移抑制因子RECK的沉默是由DNA甲基转移酶3b诱导的启动子甲基化介导的。
Cancer Res. 2006 Sep 1;66(17):8413-20. doi: 10.1158/0008-5472.CAN-06-0685.
8
Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation.DNMT3b和DNMT1的双重RNA干扰增强DNA去甲基化和基因重新激活。
Cancer Res. 2003 Oct 1;63(19):6110-5.
9
High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.人肝细胞癌中RASSF1A和p16启动子高甲基化的高频率及其与黄曲霉毒素B1-DNA加合物水平的关系
Mol Carcinog. 2002 Oct;35(2):85-92. doi: 10.1002/mc.10076.
10
DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras.DNA甲基转移酶3b促进由SV40T抗原和激活的Ras诱导的致癌转化。
Oncogene. 2003 Jul 24;22(30):4723-33. doi: 10.1038/sj.onc.1206510.

引用本文的文献

1
The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC).DNA甲基化和DNA甲基转移酶(DNMTs)在非小细胞肺癌(NSCLC)中作为潜在生物标志物和治疗靶点的作用。
Heliyon. 2024 Sep 27;10(19):e38663. doi: 10.1016/j.heliyon.2024.e38663. eCollection 2024 Oct 15.
2
Dnmt3bas coordinates transcriptional induction and alternative exon inclusion to promote catalytically active Dnmt3b expression.Dnmt3bas 协调转录诱导和选择性外显子包含,以促进具有催化活性的 Dnmt3b 表达。
Cell Rep. 2023 Jun 27;42(6):112587. doi: 10.1016/j.celrep.2023.112587. Epub 2023 Jun 8.
3
Expression of DNA Methyltransferase 3B Isoforms Is Associated with DNA Satellite 2 Hypomethylation and Clinical Prognosis in Advanced High-Grade Serous Ovarian Carcinoma.
DNA 甲基转移酶 3B 异构体的表达与高级别浆液性卵巢癌中 DNA 卫星 2 低甲基化及临床预后相关。
Int J Mol Sci. 2022 Oct 22;23(21):12759. doi: 10.3390/ijms232112759.
4
Aberrant DNA methylation in multiple myeloma: A major obstacle or an opportunity?多发性骨髓瘤中的异常DNA甲基化:主要障碍还是机遇?
Front Oncol. 2022 Aug 18;12:979569. doi: 10.3389/fonc.2022.979569. eCollection 2022.
5
DNA Methyltransferases: From Evolution to Clinical Applications.DNA 甲基转移酶:从进化到临床应用。
Int J Mol Sci. 2022 Aug 12;23(16):8994. doi: 10.3390/ijms23168994.
6
Misregulation of the expression and activity of DNA methyltransferases in cancer.癌症中DNA甲基转移酶表达和活性的调控异常。
NAR Cancer. 2021 Dec 1;3(4):zcab045. doi: 10.1093/narcan/zcab045. eCollection 2021 Dec.
7
Molecular and Cellular Insights into the Development of Uterine Fibroids.子宫纤维瘤发病机制的分子和细胞研究进展
Int J Mol Sci. 2021 Aug 6;22(16):8483. doi: 10.3390/ijms22168483.
8
The inactive Dnmt3b3 isoform preferentially enhances Dnmt3b-mediated DNA methylation.无活性的 Dnmt3b3 异构体优先增强 Dnmt3b 介导的 DNA 甲基化。
Genes Dev. 2020 Nov 1;34(21-22):1546-1558. doi: 10.1101/gad.341925.120. Epub 2020 Oct 1.
9
Dynamic Signatures of the Epigenome: Friend or Foe?动态表观基因组特征:朋友还是敌人?
Cells. 2020 Mar 7;9(3):653. doi: 10.3390/cells9030653.
10
RASSF1A Tumour Suppressor: Target the Network for Effective Cancer Therapy.RASSF1A肿瘤抑制因子:针对该网络进行有效的癌症治疗
Cancers (Basel). 2020 Jan 17;12(1):229. doi: 10.3390/cancers12010229.